.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The co-morbidity of diabetes and tuberculosis poses a significant challenge to public health systems globally. Because diabetes mellitus increases the risk of mortality and treatment failure, integrated diabetes screening in TB patients is essential. A recent study in Burundi has highlighted the feasibility and outcomes of such systematic screening programs in resource-limited settings.
In this study, researchers assessed 324 individuals diagnosed with tuberculosis. Among these patients, the prevalence of diabetes was 6.8%. Furthermore, the "number needed to test" (NNT) to identify a single case was 15, which indicates high efficiency. Predictors of diabetes included a positive family history, tobacco consumption, and unemployment. Consequently, the findings support the integration of metabolic screening within TB treatment centers.
Implementing systematic screening requires specific enablers such as healthcare worker training and free-of-charge testing. Moreover, providing diabetes treatment at the same point of care as TB therapy improves patient adherence. However, clinicians must address remaining logistical challenges to ensure a successful national rollout. In India, the National Framework for Joint Management of TB-DM already provides a roadmap for such collaborative activities. Therefore, adopting these integrated models can significantly reduce the dual burden of these diseases.
Diabetes impairs the immune system, leading to higher rates of TB treatment failure and relapse. Therefore, early detection through systematic screening helps clinicians manage both conditions simultaneously, improving patient survival.
Key predictors identified in clinical studies include a positive family history of diabetes, tobacco use, and certain socioeconomic factors like unemployment. Consequently, screening these high-risk groups can be a cost-effective strategy.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study in Burundi finds a 6.8% prevalence of DM among TB patients, with an NNT of 15, supporting the feasibility of integrated screening in low-resource ar...
4 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
